Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
When You Can't Trust The Ones Against Bad Guys.
05-22-2007, 05:12 AM,
When You Can't Trust The Ones Against Bad Guys.
Ok, I belong to many lists that send health info on it and I do alternative meds, except BP pills, thinner, and heart ? something pill. Naturally I also especially belong and have many cancer info lists I recieve and sites I visit. I recieved an email today from a suppose to be alternative med list and this is a direct quote.

"The chances of surviving cancer have doubled over 30 years, according to the charity Cancer Research UK. Cancer patients now have an average
46.2 per cent chance of living for 10 years after their initial diagnosis and survival rates have doubled over the last 30 years.

Thirty years ago a patient diagnosed with cancer had a 23.6 per cent chance of being alive after 10 years.

Women are more likely to survive than men and some cancers, including those of the lung and pancreas, are more deadly than others. In an analysis highlighting a transformation in life expectancy, the charity noted that, by 2020, two-thirds of people diagnosed with the disease should live for at least another five years.

Until tomorrow,

UK Editor"

What a line of Horse Shit. Yes people are living more years after they knew because the knew earlier, not because the disease was treated better and extended their life span, they just knew earlier. I kinda expect it from the FDA, NCA, ACS and a whole horde of money grabbing greedy, lie agencies but from an alternative site? Just a little more disinformation out there. I can say from experience that it ain't the crap they treat you with. Here's a little fact about how sweet these people are :

Copied without permission from / . Go there to read the story.
"The American Cancer Society (ACS) is accumulating great wealth in its role as a "charity." According to James Bennett, professor of economics at George Mason University and recognized authority on charitable organizations, in 1988 the ACS held a fund balance of over $400 million with about $69 million of holdings in land, buildings, and equipment (1). Of that money, the ACS spent only $90 million— 26 percent of its budget— on medical research and programs. The rest covered "operating expenses," including about 60 percent for generous salaries, pensions, executive benefits, and overhead. By 1989, the cash reserves of the ACS were worth more than $700 million (2). In 1991, Americans, believing they were contributing to fighting cancer, gave nearly $350 million to the ACS, 6 percent more than the previous year. Most of this money comes from public donations averaging $3,500, and high-profile fund-raising campaigns such
as the springtime daffodil sale and the May relay races. However, over the last two decades, an increasing proportion of the ACS budget comes from large corporations, including the pharmaceutical, cancer drug, telecommunications, and entertainment industries.
In 1992, the American Cancer Society Foundation was created to allow the ACS to actively solicit contributions of more than $100,000. However, a close look at the heavy-hitters on the Foundation's board will give an idea of which interests are at play and where the Foundation expects its big contributions to come from. The Foundation's board of trustees included corporate executives from the pharmaceutical, investment, banking, and media industries. Among them:
David R. Bethune, president of Lederle Laboratories, a multinational pharmaceutical company and a division of American Cyanamid Company. Bethune is also vice president of American Cyanamid, which makes chemical fertilizers and herbicides while transforming itself into a full-fledged pharmaceutical company. In 1988, American Cyanamid introduced Novatrone, an anti-cancer drug. And in 1992, it announced that it would buy a majority of shares of Immunex, a cancer drug maker.

Multimillionaire Irwin Beck, whose father, William Henry Beck, founded the nation's largest family-owned retail chain, Beck Stores, which analysts estimate brought in revenues of $1.7 billion in 1993.

Gordon Binder, CEO of Amgen, the world's foremost biotechnology company, with over $1 billion in product sales in 1992. Amgen's success rests almost exclusively on one product, Neupogen, which is administered to chemotherapy patients to stimulate their production of white blood cells. As the cancer epidemic grows, sales for Neupogen continue to skyrocket.

Diane Disney Miller, daughter of the conservative multi-millionaire Walt Disney, who died of lung cancer in 1966, and wife of Ron Miller, former president of the Walt Disney Company from 1980 to 1984.

George Dessert, famous in media circles for his former role as censor on the subject of "family values" during the 1970s and 1980s as CEO of CBS, and now chairman of the ACS board.

Alan Gevertzen, chairman of the board of Boeing, the world's number one commercial aircraft maker with net sales of $30 billion in 1992.

Sumner M. Redstone, chairman of the board, Viacom Inc. and Viacom International Inc., a broadcasting, telecommunications, entertainment, and cable television corporation.
The results of this board's efforts have been very successful. A million here, a million there— much of it coming from the very industries instrumental in shaping ACS policy, or profiting from it. In 1992, The Chronicle of Philanthropy reported that the ACS was "more interested in accumulating wealth than in saving lives." Fund-raising appeals
routinely stated that the ACS needed more funds to support its cancer programs, all the while holding more than $750 million in cash and real estate assets (3). A 1992 article in the Wall Street Journal, by Thomas DiLorenzo, professor of economics at Loyola College and veteran investigator of nonprofit organizations, revealed that the Texas affiliate of the ACS owned more than $11 million worth of assets in land and real estate, as well as more than 56 vehicles, including
11 Ford Crown Victorias for senior executives and 45 other cars assigned to staff members. Arizona's ACS chapter spent less than 10 percent of its funds on direct community cancer services. In California, the figure was 11 percent, and under 9 percent in Missouri (4):

Thus for every $1 spent on direct service, approximately $6.40 is spent on compensation and overhead. In all ten states, salaries and fringe benefits are by far the largest single budget items, a surprising fact in light of the characterization of the appeals, which stress an urgent and critical need for donations to provide cancer services.

Nationally, only 16 percent or less of all money raised is spent on direct services to cancer victims, like driving cancer patients from the hospital after chemotherapy and providing pain medication.

Most of the funds raised by the ACS go to pay overhead, salaries, fringe benefits, and travel expenses of its national executives in Atlanta. They also go to pay chief executive officers, who earn six-figure salaries in several states, and the hundreds of other employees who work out of so

Possibly Related Threads...
Thread Author Replies Views Last Post
  Hats off to Monsanto & their Brain Trust NickHedge 1 812 05-07-2010, 07:03 PM
Last Post: h3rm35
  What do you guys think of this! DJOldskool 12 2,494 11-23-2007, 05:22 PM
Last Post: nataraja

Forum Jump:

Users browsing this thread: 1 Guest(s)